Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure.

Iyngkaran P, Toukhsati SR, Thomas MC, Jelinek MV, Hare DL, Horowitz JD.

Clin Med Insights Cardiol. 2016 Oct 12;10:163-171. eCollection 2016. Review.

2.

Chronic Heart Failure Clinical Practice Guidelines' Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?

Abarquez RF Jr, Reganit PF, Chungunco CN, Alcover J, Punzalan FE, Reyes EB, Cunanan EL.

ASEAN Heart J. 2016 Mar 8;24:4. eCollection 2016 Mar.

3.

Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.

Tang CH, Wang CC, Chen TH, Hong CY, Sue YM.

J Am Heart Assoc. 2016 Jan 6;5(1). pii: e002584. doi: 10.1161/JAHA.115.002584.

4.

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.

Kubota Y, Asai K, Furuse E, Nakamura S, Murai K, Tsukada YT, Shimizu W.

Int J Chron Obstruct Pulmon Dis. 2015 Mar 5;10:515-23. doi: 10.2147/COPD.S79942. eCollection 2015.

5.

Nemaline myopathy and heart failure: role of ivabradine; a case report.

Sarullo FM, Vitale G, Di Franco A, Sarullo S, Salerno Y, Vassallo L, Baviera EP, Marazia S, Mandalà G, Lanza GA.

BMC Cardiovasc Disord. 2015 Jan 19;15:5. doi: 10.1186/1471-2261-15-5.

6.

New advances in beta-blocker therapy in heart failure.

Barrese V, Taglialatela M.

Front Physiol. 2013 Nov 14;4:323. doi: 10.3389/fphys.2013.00323. eCollection 2013. Review.

7.

Optimized treatment and heart rate reduction in chronic heart failure.

Moreno IB, Carlo CH, Pereira-Barretto AC.

Arq Bras Cardiol. 2013 Nov;101(5):442-8. doi: 10.5935/abc.20130201. Epub 2013 Oct 8. English, Portuguese.

8.

Partially silencing brain toll-like receptor 4 prevents in part left ventricular remodeling with sympathoinhibition in rats with myocardial infarction-induced heart failure.

Ogawa K, Hirooka Y, Kishi T, Ide T, Sunagawa K.

PLoS One. 2013 Jul 9;8(7):e69053. doi: 10.1371/journal.pone.0069053. Print 2013.

9.

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators.

Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5.

10.

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis.

Chatterjee S, Biondi-Zoccai G, Abbate A, D'Ascenzo F, Castagno D, Van Tassell B, Mukherjee D, Lichstein E.

BMJ. 2013 Jan 16;346:f55. doi: 10.1136/bmj.f55. Review. Erratum in: BMJ. 2013;346:f596.

11.

Central mechanisms of abnormal sympathoexcitation in chronic heart failure.

Kishi T, Hirooka Y.

Cardiol Res Pract. 2012;2012:847172. doi: 10.1155/2012/847172. Epub 2012 Aug 7.

12.

Sudden death prevention in heart failure: The case of CIBIS III.

Vanoli E, Dei Cas L, Willenheimer R.

Heart Int. 2006;2(2):73. doi: 10.4081/hi.2006.73. Epub 2006 Sep 30. No abstract available.

14.

Heart failure.

McKelvie RS.

BMJ Clin Evid. 2011 Aug 30;2011. pii: 0204. Review.

15.

Heart failure.

McKelvie RS.

BMJ Clin Evid. 2010 Feb 25;2010. pii: 0204. Review.

16.

Clinical evidence review: best practice heart failure.

Steimle AE.

Perm J. 2007 Spring;11(2):55-64. No abstract available.

17.

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.

Düngen HD, Apostolovic S, Inkrot S, Tahirovic E, Töpper A, Mehrhof F, Prettin C, Putnikovic B, Neskovic AN, Krotin M, Sakac D, Lainscak M, Edelmann F, Wachter R, Rau T, Eschenhagen T, Doehner W, Anker SD, Waagstein F, Herrmann-Lingen C, Gelbrich G, Dietz R; CIBIS-ELD investigators and Project Multicentre Trials in the Competence Network Heart Failure.

Eur J Heart Fail. 2011 Jun;13(6):670-80. doi: 10.1093/eurjhf/hfr020. Epub 2011 Mar 23.

18.

Congestive heart failure in Indians: how do we improve diagnosis & management?

Reddy S, Bahl A, Talwar KK.

Indian J Med Res. 2010 Nov;132:549-60. Review.

19.

Advances in systolic heart failure.

Yuzefpolskaya M, Weinberg C, Kukin M.

F1000 Med Rep. 2010 Apr 27;2. pii: 31. doi: 10.3410/M2-31.

20.

Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep.

Roumelioti ME, Ranpuria R, Hall M, Hotchkiss JR, Chan CT, Unruh ML, Argyropoulos C.

Nephrol Dial Transplant. 2010 Nov;25(11):3733-41. doi: 10.1093/ndt/gfq234. Epub 2010 Apr 29.

Supplemental Content

Support Center